Advanced Imaging Services Visikol’s expertise in multiplex tissue imaging, digital pathology, and high-content imaging within a GLP setting makes it a valuable partner for pharmaceutical companies seeking to enhance their drug discovery and validation processes through high-precision, compliant imaging solutions.

Innovative BBB Models The company’s recent development of Blood-Brain Barrier in vitro assays and expanded 3D BBB models present significant sales opportunities in neuropharmacology and CNS drug development, catering to clients targeting brain barrier penetration and transport mechanisms.

Diverse Tissue Platforms With a suite of precision tissue slice models for human and animal liver and kidney, Visikol offers tailored preclinical testing platforms, ideal for clients requiring tissue-based safety and efficacy assessments early in the drug development lifecycle.

Strategic Industry Partnerships Partnerships with leaders such as Standard BioTools enhance Visikol’s imaging capabilities, enabling a more comprehensive service offering. This positions the company favorably for clients seeking integrated, cutting-edge visualization and analysis solutions.

Comprehensive Service Portfolio From advanced tissue clearing reagents to primary hepatocyte liver models, Visikol provides end-to-end solutions that can support various stages of drug discovery, offering multiple entry points for sales engagement with biotechnology and pharmaceutical firms.